Synthetic strategies towards O6-substituted guanine derivatives and their application in medicine

Current Organic Synthesis

Volumn 2, Issue 2, 2005, Pages 215-230

  Schirrmacher, R ^a   Schirrmacher, E ^a   Muhlhausen U ^a   Kaina, B ^a   Wangler B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

AGT inhibitors; Catalysis; O6 substituted guanines; Rearrangement

Indexed keywords

EID: 30444448357     PISSN: 15701794     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570179053545369     Document Type: Review

References (122)

1. Tew, K.; Colvin, M.; Chabner, B. A. Alkylating agents. In Cancer chemotherapy: principles and practise, 2nd edition; Chabner, B. A.; Longo, D. L., Ed.; J. B. Lippincott: Philadelphia, 1995.
2. Dolan, M. E.; Mitchell, R. B.; Mummert, C.; Moschel, R. C.; Pegg, A. E. Cancer Res., 1991, 51, 3367.;
3. b) Loveless, A. Nature, 1969, 223, 206.;
4. c) Singer, B. J. Nat. Cancer Inst., 1979, 62, 1329.;
5. d) Saffhill, R.; Margison, G. P.; O'Connor, P. J. Biochim. Biophys. Acta., 1985, 823, 111.
6. Kaina, B.; Christmann, M. Int. J. Clin. Pharmacol. Ther., 2002, 40, 354.;
7. b) Ludlum, D. B. Mutat. Res., 1990, 233, 117.
8. Christmann, M.; Tomicic, M. T.; Roos, W. P.; Kaina, B. Toxicology, 2003, 193, 3.;
9. b) Erickson, L. C. Seminars in Cancer Biology, 1992, 2, 257.;
10. c) D'Incalci, M.; Citti, L.; Taverna, P.; Cata Pano, C. V. Cancer Treatment Reviews, 1988, 51, 3367.;
11. d) McElhinney, R.S.; McMurry, T.B.H.; Margison, G.P. Mini Reviews in Medicinal Chemistry, 2003, 3, 471.
12. Pegg, A. E.; Byers, T. L. FASEB J., 1992, 6, 2302.
13. Pegg, A. E.; Boosalis, M.; Samson, L.; Moschel, R. C.; Byers, T.; Swenn, K.; Dolan, M. E. Biochemistry, 1993, 32, 11998.
14. Pegg, A. E.; Dolan, M. E.; Moschel, R. C. Prog. Nucl. Acid. Res. Mol. Biol., 1995, 51, 167.
15. Liu L.; Spiro T. P.; Qin X.; Majka S.; Haaga J.; Schupp J.; Willson J.K.; Gerson S. L. Clin. Cancer. Res., 2001, 8, 2318.
16. Quinn J. A.; Pluda J.; Dolan M. E.; Delaney S.; Kaplan R.; Rich J. N.; Friedman A. H.; Reardon D. A.; Sampson J.H.; Colvin O. M.; Haglund M. M; Pegg A. E.; Moschel R. C.; McLendon R. E.; Provenzale J. M.; Gururangan S.; Tourt-Uhlig S.; Herndon J. E. 2nd; Bigner D. D.; Friedman H. S. J. Clin. Oncol., 2002, 20, 2277.
17. Moschel, R. C.; McDougall, M. G.; Dolan, M. E.; Stine, L.; Pegg, A. E. J. Med. Chem., 1992, 35, 4486.
18. Dolan, M. E.; Moschel, R. C.; Pegg, A. E. Proc. Natl. Acad. Sci. USA., 1990, 87, 5368.
19. Chae, M.-Y.; McDougall, M. G.; Dolan, M. E.; Sween, K.; Pegg. A. E.; Moschel, R. C. J. Med. Chem., 1994, 37, 342.
20. Chae, M.-Y.; Swenn, K.; Kanugula, S.; Dolan, M. E.; Pegg, A. E.; Moschel, R. C. J. Med. Chem., 1995, 38, 359.
21. Dolan, M. E.; Chae, M.-Y.; Pegg, A. E.; Mullen, J. H.; Friedman, H. S.; Moschel, R. C. Cancer Res., 1994, 54, 5123.
22. Shealy, Y. F.; Clayton, J. D.; O'Dell, C. A.; Montgomery, J. A. J. Org. Chem., 1962, 27, 4516.
23. McElhinney, R. S.; Bonnelly, D. J.; McCormick, J. E.; Kelly, J.; Watson, A. J.; Rafferty, J. A.; Elder, R. H.; Middleton, M. R.; Willington, M. A.; McMurry, T. B. H. J. Med. Chem. 1998, 41, 5265.
24. Middleton, M. R.; Kelly, J.; Thatcher, N.; Donelly, D. J.; McElhinney, R. S.; McMurry, T. B.; McCormick, J. E.; Margison, G. P. Int. J. Cancer, 2000, 85, 248.
25. Arris, C. E.; Bleasdale, C.; Calvert, A. H.; Curtin, N. J.; Dalby, C.; Golding, B. T.; Griffin, R. J.; Lunn, J. M.; Major, G. N.; Newell, D. R. Anti. Cancer Drug. Des., 1994, 9, 359.
26. Crone, T. M.; Goodtzova, K.; Edara, S.; Pegg, A. E. Cancer Res., 1994, 54, 6221.;
27. b) Xu-Welliver, M.; Kanugula, S.; Pegg, A. E. Cancer Res., 1998, 59, 1936.;
28. Xu-Welliver, M.; Leitao, J.; Kanugula, S.; Pegg, A. E. Cancer Res., 1999, 59, 1514.;
29. Xu-Welliver, M.; Leitao, J.; Kanugula, S.; Meehan, W. J.; Pegg, A. E. Biochem. Pharmacol., 1999, 58, 1279.
30. Griffin, R. J.; Arris, C. E.; Bleasdaly, C.; Boyle, F. T.; Calvert, A. H.; Curtin, N. J.; Dalby, C.; Kanugula, S.; Lembicz, N. K.; Newell, D. R.; Pegg, A. E.; Golding, B. T. J. Med. Chem., 2000, 43, 4071.
31. Balsinger, R. W.; Montgomery, J. A. J. Org. Chem. Soc., 1960, 25, 1573.
32. Frihart, C. R.; Leonard, N. J. J. Am. Chem. Soc., 1973, 95, 7174.
33. Reinhard, J.; Hull, W. E.; von der Lieth, C.-W.; Eichhorn, U.; Kliem, H.-C.; Kaina, B.; Wiessler, M. J. Med. Chem., 2001, 44, 4050.
34. Reinhard, J.; Eichhorn, U.; Wiessler, M.; Kaina, B. Int. J. Cancer, 2001, 93, 373.
35. Arris, C. E.; Boyle, T.; Calvert, H.; Curtin, N. J.; Endicott, J. A.; Garman, E. F.; Gibson, A. E.; Golding, B. T.; Grant, S.; Griffin, R. J.; Jewsbury, P.; Johnson, L. N.; Lawrie, A. M.; Newell, D. R.; Noble, M. E. M.; Sausville, E. A.; Schulz, R.; Yu, W. J. Med. Chem., 2000, 43, 2797.
36. Senderowicz, A. M.; Sausville, E. A. J. Natl. Cancer Inst. 2000, 92, 376;
37. b) Meijer, I.; Leclerc, L.; Leost, M. Pharmacol. Ther., 1999, 82, 279.
38. Gibson, A. E. G.; Arris, C. E.; Bentley, J.; Boyle, T.; Curtin, N. J.; Davis, T. G.; Endicott, J. A.; Golding, B. T.; Grant, S.; Griffin, R. J.; Jewsbury, P.; Johnson, L. N.; Mesguiche, V.; Newell, D. R.; Noble, M. E. M.; Tucker, J. A.; Whitfield, H. J. J. Med. Chem., 2002, 45, 3381.
39. Imbach, P.; Capraro, H.-G.; Furet, P.; Mett, H.; Meyer, T.; Zimmermann, Bioorg. Med. Chem. Lett., 1999, 9, 91.
40. Schow, S. R.; Mackman, R. I.; Blum, C. L.; Brooks, E.; Horsma, A. G.; Joly, A.; Kerwar, S. S.; Lee, G.; Shiffman, D.; Nelson, M. G.; Wang, X.; Wick, M. M.; Zhang, X.; Lum, R. T. Bioorg. Med. Chem. Lett., 1997, 7, 2697.
41. Legraverend, M.; Ludwig, O.; Bisagni, E.; Leclerc, S.; Meijer, L. Bioorg. Med. Chem. Lett., 1998, 8, 793.
42. Chen, X.; Kern, E. R.; Drach, J. C.; Gullen, E.; Cheng, Y.-C.; Zemlicka, J. J. Med. Chem., 2003, 46, 1531.
43. Vince, R.; Kilama, J.; Pham, P. T.; Beers, S. A.; Bowdon, B. J.; Keith, K. A.; Parker, W. B. Nucleosides Nucleotides, 1995, 14, 1703.
44. Schirrmacher, R.; Mühlhausen, U.; Wängler, B.; Schirrmacher, E.; Reinhard, J.; Nagel, G.; Kaina, B.; Piel, M.; Wießler, M.; Rösch, F. Tetrahedron Lett., 2002, 43, 6301.
45. Schirrmacher, R.; Nesseler, E.; Hamkens, W.; Eichhorn, U.; Schreckenberger, M.; Kaina, B.; Rösch, F. Appl. Radiat. Isot., 2002, 56, 511.
46. Vaidyanathan, G.; Affleck, D. J.; Cavazos, C. M.; Johnson, S. P.; Shankar, S.; Friedman, H. S.; Colvin, M. O.; Zalutsky, M. R. Bioconjugate Chem., 2000, 11, 868.
47. Mounetou, E.; Cussac, C.; Mathieu, F.; Maurizis, J.-C.; Labarre, P.; Moreau, M.-F.; Veyre, A.; Madelmont, J.-C. J. Label. Compd. Radiopharm., 1995, 36, 1215.
48. 18F-alcohol concentration would be extremely substoichiometric.
49. Zheng, Q.-H.; Liu, X.; Fei, X.; Wang, J.-Q.; Ohannesian, D. W.; Erickson, L. C.; Lee Stone, K.; Martinez, T. D.; Miller, K. D.; Hutchins, G. D. J. Label. Compd. Radiopharm., 2002, 45, 1239.
50. Liu, X.; Zheng, Q.-H.; Hutchins, G. D.; Fei, X.; Erickson, L. C.; Miller, K. D.; Mock, B. H.; Glick-Wilson, B. E.; Winkle, W. L.; Stone, K. L.; Carlson, K. A. Synth. Commun., 2003, 33, 941.
51. Liu, X.; Zheng, Q.-H.; Fei, X.; Wang, J.-Q.; Ohannesian, D. W.; Erickson, L. C.; Stone, K. L.; Hutchins, G. D. Bioorg. Med. Chem. Lett., 2003, 13, 641.
52. Boiteux, J.; Laval, F. Carcinogenesis, 1985, 6, 805.
53. Ciocco, G. M.; Moschel, R. C.; Chae, M.-Y.; McLaughlin, P. J.; Zagon, I. S.; Pegg, A. E. Cancer Res., 1995, 55, 4085.
54. Madelmont, J. C.; Cussa, C.; Dupuy, J. M.; Rapp, M.; Labarre, P.; Chabarad, J. L.; Maurizis, J. C.; Sauzieres, J.; Baudry, J. P.; Godeneche, D.; Veyre, A. J. Label. Compd. Radiopharm., 1992, 31, 793.
55. Dolan, M. E.; Scicchitano, D.; Pegg, A. E. Cancer Res., 1988, 48, 1184.
56. Souliotis, V. L.; Zongza, V.; Nikolopoulos, V.; Dimitriadis, G. L. Comp. Biochem. Physiol., 1992, 101B, 269.
57. Lolli, M.; Medana, C.; Romagnano, S.; Castoldi, F.; Pozzoli, S.; Vago, F.; Fanelli, R.; Airoldi, L. J. Label. Compd. Radiopharm., 1998, 3, 243.
58. Beynon, J. H.; Hopkinson, J. A.; Williams, A. E. Org. Mass Spectrom., 1968, 1, 169.
59. Sato; Jpn. Kokai Tokkyo Koho JP 05213952 A2 930824 Heisei; Chem. Abstr., 1994, 120, 8412.
60. Igi, T. Hayashi; Eur. Pat. Appl. EP 543095 A2 930526; Chem. Abstr., 1993, 119, 180812.
61. Hanson, C. PCT Int. Appl. WO 92113859 A1 920820; Chem. Abstr., 1992, 117, 233720.
62. Killen, R. J. PCP Int. Appl. WO 9315075 A1 930805; Chem. Abstr., 1994, 120, 30779.
63. Zhou, J.; Tsai, J.-Y.; Bouhadir, K.; Shevlin, P. B. Synth. Commun., 1999, 29, 3003.
64. Unpublished results from our laboratory show that reaction times of more than 2 h lead to a total mono deacetylation in 9-position of the 2-amino-purine (guanine).
65. Shaw, G.; Comprehensive Heterocyclic Chemistry, Pergamon Press, 1984, Vol 5, pp. 499.
66. Nasutavicus, W. A.; Love, J. J. Heterocyclic Chem., 1974, 11, 77.
67. The authors stated that crystallization of the product set in when the solution was evaporated. To our experience it is essential to evaporate at room temperature because higher temperatures using a vacuum evaporator lead to unwanted side reactions and reduced the yield significantly. In the worst case, no crystallization was observed.
68. Simon, A. B.; Brit. Pat. 767216, 1957; Chem. Abst. 1957, 51, 14796d.
69. Burroughs Wellcome & Co. US 2815346, 1955; Chem. Abst. 1958, 52, 6417b.
70. These unpublished results were obtained in our laboratory. The reaction time of bubbling chlorine through the solution should not exceed 10 h. It is essential to reduce the volume of the reaction mixture at room temperature (25°C) by half. Then precipitation of 3 set in.
71. Beaman, A. G.; Gerster, J. F.; Robins, R. K. J. Org. Chem. 1962, 27, 986.
72. Daves, G. D. Jr.; Noell, C. W.; Robins, R. K.; Koppel, H. C.; Beaman, A. G. J. Am. Chem. Soc., 1960, 82, 2633.
73. Bowels, W. A.; Schneider, F. H.; Lewis, L. R.; Robins, R. K. J. Med. Chem., 1963, 6, 471.
74. Kilburis, J.; Lister, J. H. J. Chem. Soc. (C), 1971, 3942.
75. Linn, J. A.; McLean, E. W.; Kelly, J. L. J. Chem. Soc., Chem. Commun., 1994, 913.
76. Schirrmacher, R.; Wängler, B.; Schirrmacher, E.; August, T.; Rösch, F. Synthesis, 2002, 4, 538.
77. The authors would like to indicate that the published yield of the trimethyl ammonium salt (4) of 79 % can be enhanced up to 95 % by reducing the final DMSO solution by half before adding diethyl ether.
78. Ashwell, M.; Bleasdale, C.; Golding, B. T.; O'Neill, I. K. J. Chem. Soc., Chem. Commun., 1990, 955.
79. 6-ether moiety.
80. Lembicz, N. K.; Grant, S.; Clegg, W.; Griffin, R. J.; Heath, S. L.; Golding, B. T. J. Chem. Soc., Perkin Trans 1, 1997, 1, 185.
81. Långström, B.; Kihlberg, T.; Bergstöm, M.; Antoni, G.; Björkman, M.; Forngren, B. H.; Forngren, T.; Hartvig, P.; Markides, K.; Yngve, U.; Ögren, M. Acta. Chem. Scand., 1999, 53, 651.
82. Kaneko, C.; Momose, Y. Synthesis, 1982, 465.
83. Adamiak, R. W.; Biala, E.; Skalski, B. Angew. Chem., 1985, 97, 1046.
84. Adamiak, R. W.; Biala, E.; Gdaniec, Z.; Mielewczyk, S. Chemica Scripta, 1986, 26, 3.
85. Huynh-Dinh, T.; d'Estaintot, L.; Allard, P.; Igolen, J. Tetrahedron Lett., 1985, 26, 431.
86. Reese, C. B.; Skone, P. A. J. Chem. Soc. Perkin Trans. 1, 1984, 1263.
87. Skalski, B.; Paszyk, S.; Adamina, R. W.; Steer, R. P.; Verrall, R. E. Can. J. Chem., 1990, 68, 2164.
88. Höfle, G.; Steglich, W.; Vorbrüggen, H. Angew. Chem., 1978, 90, 602;
89. b) Hassner, A.; Krepski, L. R.; Alexanian, V. Tetrahedron, 1978, 34, 2069;
90. c) Scriven, E. F. V. Chem. Soc. Rev., 1983, 13, 129.
91. Keppler, A.; Gendreizig, S.; Gronemeyer, T.; Pick, H.; Vogel, H.; Johnsson, K. Nat. Biotechnol., 2003, 21, 86.
92. Jenny, T. F.; Benner, S. A. Tetrahedron Lett., 1992, 33, 6619.
93. Jenny, T. F.; Schneider, K. C.; Benner, S. A. Nucleosides & Nucleotides, 1992, 11, 1257.
94. Kjellberg, J.; Liilijenberg, M. Tetrahedron Lett., 1986, 27, 877.
95. Loeppky, R. N.; Yu, Li.; Gu, F.; Ye, Q. J. Am. Chem. Soc., 1996, 118, 10995.
96. Safadi, M.; Bindna, D.; Williams, T.; Moschel, R. C.; Sella, V. J. Int. J. Pharm., 1993, 90, 239.
97. Gao, X.; Gaffney, B. L.; Hadden, S.; Jones, R. A. J. Org. Chem., 1986, 51, 755.
98. Zou, R.; Robins, M. Can. J. Chem., 1987, 65, 1436.
99. Kamimura, T.; Tsuchiya, M.; Urakami, K.-I.; Kouro, K.; Sekine, M.; Shinozaki, K.; Miura, K.-I.; Hata, T. J. Am. Chem. Soc., 1984, 106, 4552.
100. Balu, N.; Gamcsik, M. P.; Colvin, M. E.; Colvin, O. M.; Dolan, M. E.; Ludeman, S. M. Chem. Res. Toxicol., 2002, 15, 380.
101. Chida, N.; Susuki, T.; Tanaka, S.; Yamada, I. Tetrahedron Lett., 1999, 40, 2573.
102. Xu, M.; Giacomo, F. D.; Paterson, D. E.; George, T. G.; Vasella, A. Chem. Commun., 2003, 1452.
103. Thermal processes: a) Fuchs, H.; Gottlieb, M.; Pfleiderer, W. Chem. Ber., 1978, 111, 982.;
104. b) Shamin, M. T.; Ukena, D.; Padgett, W, L.; Daly, J. W. J. Med. Chem., 1989, 32, 1231.;
105. c) Rybár, A.; Alföldi, J.; Federonko, M.; Kozák, J. Synthesis, 1996, 459.;
106. reduction: a) Kempter, F. E.; Rokos, H.; Pfleiderer, W. Chem. Ber., 1970, 103, 885.;
107. b) Kavai, I.; Mead, L. M.; Drobniak, J.; Zakrzewski, S. F. J. Med. Chem., 1975, 18, 272.;
108. c) Moore, A. G.; Schow, S. R.; Lum, R. T.; Nelson, M. G.; Melville, C. R. Synthesis, 1999, 1123.;
109. Mannich base: Taylor, E. C. and Garcia, E. E. J. Am. Chem. Soc.; 1964, 86, 4720.;
110. Vilsmeier-Haak reagents: a) Yoneda, F.; Higuchi, M.; Matsumura, T.; Senga, K. Bull. Chem. Soc. Jpn., 1973, 1836.;
111. b) Melguizo, M.; Nogueras, M.; Sánches, A. J. Org. Chem., 1992, 57, 559.;
112. 1,1-dimethylhydrazones: Yoneda, F.; Nagamatsu, T. J. Chem. Soc., Perkin Trans. 1, 1976, 35, 1547.
113. Pfleiderer, W. and Lohrmann, R. Chem. Ber., 1961, 94, 12.
114. Robins, M. J; Robins, R. K. J. Org. Chem., 1969, 34, 2160.
115. Bowels, W. A.; Schneider, F. H.; Lewis, L. R.; Robins, R. K. J. Med. Chem., 1963, 6, 471.
116. Optimization of this method was achieved in our laboratory. The temperature should not exceed 80°C and the benzylacohol must be freshly distilled and oxygen free.
117. These observations were made in our laboratory during optimization of the literature procedure.
118. Koyama, K.; Hitomi, K.; Terashima, I.; Kohda, K. Chem. Pharm. Bull., 1996, 44, 1395.
119. Sprinzak, Y. J. Am. Chem. Soc., 1956, 78, 3207.
120. MacCross, M.; Chen, A.; Tolman, R. L. Tetrahedron Lett., 1985, 26, 1815.
121. Barth; C.; Seitz, O.; Kunz, H.; Z. Naturforsch., 2004, 59b, 802.
122. Leonard, N. J.; Frihart, C. R. J. Am. Chem. Soc., 1974, 96, 5894.